A

Adaptive Biotechnologies Corp
D

ADPT

8.27000
USD
-0.07
(-0.78%)
مغلق
حجم التداول
73,547
الربح لكل سهم
-1
العائد الربحي
-
P/E
-6
حجم السوق
1,222,088,863
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    ILMN
    ILMN
    -3.080
    (-3.17%)
    94.180 USD
    M
    MTD
    -16.62
    (-1.28%)
    1,286.54 USD
    M
    MYGN
    -0.790
    (-5.27%)
    14.190 USD
    O
    OPK
    0.00500
    (0.30%)
    1.67500 USD
    P
    PODD
    -5.82
    (-2.02%)
    282.56 USD
    TMO
    TMO
    -5.71
    (-1.06%)
    532.28 USD
    T
    TNDM
    -1.110
    (-3.45%)
    31.020 USD
    V
    VEEV
    -2.960
    (-1.29%)
    225.900 USD
    المزيد
الأخبار
المقالات

العنوان: Adaptive Biotechnologies Corp

القطاع: Healthcare
الصناعة: Biotechnology
Adaptive Biotechnologies Corp is a company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product,clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease (MRD) in patients with multiple myeloma (MM), B cell acute lymphoblastic leukemia (ALL) and chronic lymphocytic leukemia (CLL) and is alsoavailable as a CLIA-validated laboratory developed test (LDT) for patients with other lymphoid cancers, including diffuse large B-cell lymphoma (DLBCL).